News

Eurostars R&D Project, Jan 2017

ImmunoSYS has started a 2-year project, ‘COMPIT’, to research and develop a novel in vitro human immune analytical platform for preclinical drug immunogenicity testing. The project is in collaboration with the Dutch company Abundnz BV and receives a EU funding through the Innovate UK.

 

Welcome to ImmunoSYS

What We Do

home2

Biological capacity development

Analytical services (biomolecular)

Modelling of biological mechanisms

Research

We work with organisations of all sizes including academic institutes, life science investors, start-up companies and established organisations.

ImmunoSYS is an R&D focused company. We work together with academia and biotech groups to develop innovative products and systems through research.

 

NEW VENTURE IN DRUG SAFETY ANALYSIS

ImmunoSYS and Abundnz BV joined forces and started a new CRO, Immundnz (www.immundnz.com) in 2017, that offers an innovative platform for the comprehensive immune analysis of drug molecules. Immundnz has its laboratory based at the BioHub at Alderley Park in Cheshire (UK).